Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
<p>Proteomics: DE and Reactome of Cyt proteins</p>
Αποθηκεύτηκε σε:
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
ανά: Andrés Elía (15055031)
Έκδοση: (2025) -
Supplementary Table S5 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
ανά: Andrés Elía (15055031)
Έκδοση: (2025) -
Supplementary Table S7 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
ανά: Andrés Elía (15055031)
Έκδοση: (2025) -
Supplementary Table S8 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
ανά: Andrés Elía (15055031)
Έκδοση: (2025) -
Figure 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
ανά: Nigel Bundred (15046233)
Έκδοση: (2025)